← All patents

US11684657B2

HLA-restricted VGLL1 peptides and use thereof in promoting an immune response …

University of Texas System

Abstract

Provided herein are tumor-antigen VGLL1 specific peptides. Also provided herein are methods of generating VGLL1-specific T cells and their use for the treatment of cancer. In addition, the VGLL1-specific peptides may be used as a vaccine.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Gregory LIZÉE
Priority date
October 07, 2016
Filing date
October 05, 2017
Grant date
June 27, 2023
Publication date
June 27, 2023
Language
en
Metadata fetched
August 29, 2026 00:30